Republicans Question CBO Estimate on Medicaid Funding Cuts

A recent preliminary estimate from the Congressional Budget Office (CBO) regarding the impact of cutting Medicaid funding for child sex-change procedures has prompted skepticism among Republicans.

The estimate, obtained by The Daily Signal, indicates that the projected savings from halting Medicaid funds for gender-transition procedures are only about half of what Republicans had expected. Initially, Republicans believed that these prohibitions would save taxpayers approximately $1.4 billion over a decade as part of the House’s budget reconciliation bill. However, the CBO’s estimate now suggests the figure is closer to $700 million.

The CBO’s role involves analyzing legislation and providing Congress with a fiscal score that outlines the potential effects on federal spending, revenues, and deficits.

Despite the CBO scores being a vital part of the legislative framework, Rep. Ralph Norman from South Carolina expressed his doubts during a phone interview, citing past inaccuracies from the CBO. He noted a previous score that suggested illegal immigration was a net positive for the deficit.

“This doesn’t surprise me,” Norman remarked. “It doesn’t change anything. I mean, if you’re in the situation we’re in now, you take what you can get.”

The preliminary score represents an early assessment of a bill’s fiscal impact and can change as the legislative process continues. As Congress works on revising the reconciliation package over the weekend, the CBO will need to adjust its estimates accordingly.

Before the Energy and Commerce Committee’s markup took place, Democrats had acquired a preliminary CBO estimate indicating that their budget reconciliation proposals could lead to a deficit reduction of at least $912 billion over the 2025-2034 timeline.

When asked if the House might discover further savings by expanding the ban on Medicaid funding for these gender-transition procedures, Norman suggested, “I imagine so.”

Costs for individual transgender interventions can exceed $75,000, as reported by the Human Rights Campaign, a leading advocate for gender-related issues.

Public sentiment generally leans against using taxpayer funds for transgender medical interventions. A survey by the American Principles Project found that about 66% of Americans oppose taxpayer funding for gender-transition procedures, while a recent Associated Press study indicated that 53% of Americans disfavor taxpayer support for “gender-affirming care,” which includes puberty blockers and hormone therapy.

A senior legislative aide stated that eliminating taxpayer dollars for child gender transitions not only saves money but also aligns with moral principles, emphasizing that the intended benefits of the Do No Harm in Medicaid Act go beyond financial savings.